DIN 02543559 — ELREXFIO 44 MG
ELREXFIO is a solution of Elranatamab marketed by PFIZER CANADA ULC. The full Elranatamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02543559
- Brand name
- ELREXFIO
- Active ingredient
- Elranatamab
- Strength
- 44 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- BCMA-directed and CD3-directed bispecific antibody (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Elranatamab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02543567 | ELREXFIO | 76 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |